Park MO - Search Results

1

Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonins in rats.

Yoo SD, Jun H, Shin BS, Lee HS, Park MO, Deluca PP, Lee KC. Yoo SD, et al. Among authors: park mo. Chem Pharm Bull (Tokyo). 2000 Dec;48(12):1921-4. doi: 10.1248/cpb.48.1921. Chem Pharm Bull (Tokyo). 2000. PMID: 11145145

2

Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.

Lee KC, Park MO, Na DH, Youn YS, Lee SD, Yoo SD, Lee HS, DeLuca PP. Lee KC, et al. Among authors: park mo. Calcif Tissue Int. 2003 Dec;73(6):545-9. doi: 10.1007/s00223-002-0034-9. Epub 2003 Sep 29. Calcif Tissue Int. 2003. PMID: 14508623

3

Preparation and characterization of polyethylene-glycol-modified salmon calcitonins.

Lee KC, Tak KK, Park MO, Lee JT, Woo BH, Yoo SD, Lee HS, DeLuca PP. Lee KC, et al. Among authors: park mo. Pharm Dev Technol. 1999 May;4(2):269-75. doi: 10.1081/pdt-100101361. Pharm Dev Technol. 1999. PMID: 10231888

4

Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins.

Lee KC, Moon SC, Park MO, Lee JT, Na DH, Yoo SD, Lee HS, DeLuca PP. Lee KC, et al. Among authors: park mo. Pharm Res. 1999 Jun;16(6):813-8. doi: 10.1023/a:1018861616465. Pharm Res. 1999. PMID: 10397599

5

Identification of the modifying sites of mono-PEGylated salmon calcitonins by capillary electrophoresis and MALDI-TOF mass spectrometry.

Na DH, Park MO, Choi SY, Kim YS, Lee SS, Yoo SD, Lee HS, Lee KC. Na DH, et al. Among authors: park mo. J Chromatogr B Biomed Sci Appl. 2001 Apr 15;754(1):259-63. doi: 10.1016/s0378-4347(00)00599-5. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11318423

6

Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.

Woo BH, Lee JT, Park MO, Lee KR, Han JW, Park ES, Yoo SD, Lee KC. Woo BH, et al. Among authors: park es, park mo. Arch Pharm Res. 1999 Oct;22(5):459-63. doi: 10.1007/BF02979153. Arch Pharm Res. 1999. PMID: 10549572

7

Two-phase melt systems of ibuprofen for enhanced membrane permeation.

Kang L, Park MO, Jun HW. Kang L, et al. Among authors: park mo. Pharm Dev Technol. 2004 Nov;9(4):349-57. doi: 10.1081/pdt-200032991. Pharm Dev Technol. 2004. PMID: 15581071

8

Solubility of (+/-)-ibuprofen and S (+)-ibuprofen in the presence of cosolvents and cyclodextrins.

Nerurkar J, Beach JW, Park MO, Jun HW. Nerurkar J, et al. Among authors: park mo. Pharm Dev Technol. 2005;10(3):413-21. doi: 10.1081/pdt-54446. Pharm Dev Technol. 2005. PMID: 16176022

9

Effects of formulation variables and characterization of guaifenesin wax microspheres for controlled release.

Mani N, Park MO, Jun HW. Mani N, et al. Among authors: park mo. Pharm Dev Technol. 2005;10(1):71-83. doi: 10.1081/pdt-49658. Pharm Dev Technol. 2005. PMID: 15776815

10

Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.

Nerurkar J, Jun HW, Price JC, Park MO. Nerurkar J, et al. Among authors: park mo. Eur J Pharm Biopharm. 2005 Sep;61(1-2):56-68. doi: 10.1016/j.ejpb.2005.03.003. Eur J Pharm Biopharm. 2005. PMID: 15893919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters